Drug delivery by red blood cells

IUBMB Life

Volumn 63, Issue 8, 2011, Pages 621-631

  Biagiotti, Sara ^a   Paoletti, Maria Filomena ^a   Fraternale, Alessandra ^a   Rossi, Luigia ^a   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

carrier red blood cells; drug delivery; immunosuppressive drugs

Indexed keywords

ALCOHOL DEHYDROGENASE; ALCOHOL OXIDASE; ALDEHYDE DEHYDROGENASE; ALGLUCERASE; ARGINASE; ASPARAGINASE; BETA GLUCURONIDASE; CATALASE; CYCLOSPORIN A; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; DRUG BINDING PROTEIN; FLUDARABINE PHOSPHATE; FORMATE DEHYDROGENASE; GALACTOSIDASE; GLUCOCORTICOID; GLUCOSE OXIDASE; GLUTAMATE DEHYDROGENASE; HEXOKINASE; IMMUNOPHILIN; PHOSPHOTRIESTERASE; RECOMBINANT PROTEIN; STREPTOKINASE; TACROLIMUS; THYMIDINE PHOSPHORYLASE; UNINDEXED DRUG; URATE OXIDASE; UROKINASE; ZALCITABINE; ZIDOVUDINE 5' PHOSPHATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALCOHOL INTOXICATION; ANAPHYLAXIS; BIOENGINEERING; CARDIOVASCULAR SYSTEM; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHINGOID SYNDROME; DEVICE; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG RELEASE; DRUG TOLERABILITY; DRUG TRANSPORT; DYNAMICS; ENCAPSULATION; ERYTHROCYTE; GAUCHER DISEASE; GLAUCOMA; GLOMERULUS FILTRATION RATE; GLUCOSE INTOLERANCE; HUMAN; HYPERAMMONEMIA; HYPERARGININEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; INTOXICATION; LYSOSOME STORAGE DISEASE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; REVIEW; SIDE EFFECT; SKIN ATROPHY; TECHNOLOGY; THROMBOSIS;

ANTI-INFLAMMATORY AGENTS; BIOREACTORS; DRUG CARRIERS; ERYTHROCYTES; HUMANS;

EID: 79960814336     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.478     Document Type: Review

References (88)

1. DeLoach, J. R., and, Way, J. L., (1994) Carrier and Bioreactors Red Blood Cells for Drug Delivery and Targeting. Elsevier Science Ltd., Great Britain.
2. Magnani, M., and, DeLoach JR., (1992) The Use of Resealed Erythrocytes as Carriers and Bioreactors. Plenum Press, New York and London.
3. Sprandel, U., and, Way, J. L., (1997) Erythrocytes as Drug Carriers in Medicine. Plenum Press, New York and London.
4. Hamidi, M., Zarrin, A., Foroozesh, M., and, Mohammadi-Samani, S., (2007) Applications of carrier erythrocytes in delivery of biopharmaceuticals. J. Control Release 118, 145-160. (Pubitemid 46329734)
5. Muzykantov, V. R., (2010) Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert. Opin. Drug Deliv. 7, 403-427.
6. Pierige, F., Serafini, S., Rossi, L., and, Magnani, M., (2008) Cell-based drug delivery. Adv. Drug Deliv. Rev. 60, 286-295. (Pubitemid 350236405)
7. Da Silva, J. A., Jacobs, J. W., Kirwan, J. R., Boers, M., Saag, K. G., et al. (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann. Rheum. Dis. 65, 285-293. (Pubitemid 43268214)
8. D'ascenzo, M., Antonelli, A., Chiarantini, L., Mancini, U., and, Magnani, M., (1997) Red blood cells as a glucocorticoid delivery systems. In Erythrocytes as Drug Carriers in Medicine (, Sprandel, U., and, Way, J. L., eds.). pp. 81-89, Plenum Press, New York.
9. Rossi, L., Serafini, S., Cenerini, L., Picardi, F., Bigi, L., et al. (2001) Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease. Biotechnol. Appl. Biochem. 33, 85-89. (Pubitemid 32304285)
10. Rossi, L., Castro, M., D'Orio, F., Damonte, G., Serafini, S., et al. (2004) Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients. Blood Cells Mol. Dis. 33, 57-63. (Pubitemid 38829599)
11. Knafelz, D., D'Orio, F., Papadatou, B., Magnani, M., Rossi, L., et al. (2002) Treatment with autologous erythrocytes loaded with dexamethasone 21-phosphate in inflammatory disease of the gut. Gut 51, A323.
12. Castro, M., Rossi, L., Papadatou, B., Bracci, F., Knafelz, D., et al. (2007) Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease. J. Pediatr. Gastroenterol. Nutr. 44, 423-426. (Pubitemid 46573223)
13. Castro, M., Knafelz, D., Rossi, L., Ambrosini, M. I., Papadatou, B., et al. (2006) Periodic treatment with autologous erythrocytes loaded with dexamethasone 21-phosphate for fistulizing pediatric Crohn's disease: case report. J. Pediatr. Gastroenterol. Nutr. 42, 313-315.
14. Annese, V., Latiano, A., Rossi, L., Lombardi, G., Dallapiccola, B., et al. (2005) Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients-a pilot uncontrolled study. Am. J. Gastroenterol. 100, 1370-1375. (Pubitemid 40904364)
15. Bossa, F., Latiano, A., Rossi, L., Magnani, M., Palmieri, O., et al. (2008) Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study. Am. J. Gastroenterol. 103, 2509-2516.
16. Schimmer, B. P., and, Patel, K., (1996) Adrenocorticotropic hormone. In The Pharmacological Basis of Therapeuctis (, Hardman, J. G., and, Limberd, L. E., eds.). pp. 1458-1485, McGraw-Hill, New York.
17. Magnani, M., Giovine, M., Fraternale, A., Damonte, G., Rossi, L., et al. (1994) Red blood cells as a delivery system for AZT. Drug Deliv. 2, 57-61.
18. Magnani, M., Bianchi, M., Rossi, L., and, Stocchi, V., (1989) Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity. Biochem. Biophys. Res. Commun. 164, 446-452. (Pubitemid 19269753)
19. Rodriguez, G., (1994) Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma. Invest. New Drugs 12, 75-92. (Pubitemid 24350644)
20. Fraternale, A., Rossi, L., and, Magnani, M., (1996) Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes. Biochim. Biophys. Acta 1291, 149-154. (Pubitemid 26348768)
21. Pierigè, F., De Marco, C., Orlotti, N., Dominici, S., Biagiotti, S., et al. (2010) Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines. Int. J. Oncol. 37, 133-142.
22. Chabner, B. A., (1982) Pharmacological Principles of Cancer Treatment. Sunders, Philadelphia.
23. De Flora, A., Zocchi, E., Guida, L., Polvani, C., and, Benatti, U., (1988) Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes. Proc. Natl. Acad. Sci. USA 85, 3145-3149.
24. Gasparini, A., Mazzei, M., Grandi, T., Balbi, A., Tonetti, M., et al. (1994) Human red blood cells (RBC) as bioreactors for the production and the release of fluoropyrimidine drugs from encapsulated pro-drugs. Adv. Biosci. 92, 51.
25. Benatti, U., Giovine, M., Damonte, G., Gasparini, A., Scarfi, S., et al. (1996) Azidothymidine homodinucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine. Biochem. Biophys. Res. Commun. 220, 20-25. (Pubitemid 26106792)
26. Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., et al. (2005) Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353, 38-52. (Pubitemid 41338838)
27. Sudlow, G., Birkett, D. J., and, Wade, D. N., (1976) Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 12, 1052-1061.
28. Hopkins, A. L., and, Groom, C. R., (2002) The druggable genome. Nat. Rev. Drug Discov. 1, 727-730. (Pubitemid 37361545)
29. Schmidtke, P., and, Barril, X., (2010) Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. J. Med. Chem. 53, 5858-5867.
30. Thangudu, R. R., Tyagi, M., Shoemaker, B. A., Bryant, S. H., Panchenko, A. R., et al. (2010) Knowledge-based annotation of small molecule binding sites in proteins. BMC Bioinform. 11, 365.
31. Lomenick, B., Hao, R., Jonai, N., Chin, R. M., Aghajan, M., et al. (2009) Target identification using drug affinity responsive target stability (DARTS). Proc. Natl. Acad. Sci. USA 106, 21984-21989.
32. Barik, S., (2006) Immunophilins: for the love of proteins. Cell Mol. Life Sci. 63, 2889-2900. (Pubitemid 46072296)
33. Siekierka, J. J., Hung, S. H., Poe, M., Lin, C. S., and, Sigal, N. H., (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341, 755-757. (Pubitemid 19260892)
34. Harding, M. W., Galat, A., Uehling, D. E., and, Schreiber, S. L., (1989) A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341, 758-760. (Pubitemid 19260893)
35. Chow, F. S., Piekoszewski, W., and, Jusko, W. J., (1997) Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab. Dispos. 25, 610-616. (Pubitemid 27213103)
36. Walensky, L. D., Gascard, P., Fields, M. E., Blackshaw, S., Conboy, J. G., et al. (1998) The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1. J. Cell Biol. 141, 143-153. (Pubitemid 28182647)
37. Foxwell, B. M., Frazer, G., Winters, M., Hiestand, P., Wenger, R., et al. (1988) Identification of cyclophilin as the erythrocyte ciclosporin-binding protein. Biochim. Biophys. Acta 938, 447-455. (Pubitemid 18067092)
38. Reichel, C., von, F. M., Brockmeier, D., and, Dengler, H. J., (1994) Characterization of cyclosporine A uptake in human erythrocytes. Eur. J. Clin. Pharmacol. 46, 417-419. (Pubitemid 24199201)
39. Naesens, M., Kuypers, D. R., and, Sarwal, M., (2009) Calcineurin inhibitor nephrotoxicity. Clin. J. Am. Soc. Nephrol. 4, 481-508.
40. Armenti, V. T., Moritz, M. J., and, Davison, J. M., (1998) Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf. 19, 219-232. (Pubitemid 28432930)
41. Kershner, R. P., and, Fitzsimmons, W. E., (1996) Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation 62, 920-926. (Pubitemid 26360352)
42. Tsunoda, S. M., and, Aweeka, F. T., (2000) Drug concentration monitoring of immunosuppressive agents: focus on tacrolimus, mycophenolate mofetil and sirolimus. BioDrugs 14, 355-369. (Pubitemid 32105545)
43. Biagiotti, S., Rossi, L., Bianchi, M., Giacomini, E., Pierigè, F., et al. (2011) Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs. Submitted.
44. Magnani, M., Rossi, L., Bianchi, M., Serafini, G., Zocchi, E., et al. (1989) Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes. Biotechnol. Appl. Biochem. 11, 439-444. (Pubitemid 19239235)
45. DeLoach, J. R., (1985) Dialysis method for entrapment of proteins into resealed red blood cells. In Methods in Enzymology. (, Green, R., and, Widder, K. S., eds.). pp. 235-242, Academic Press, San Diego.
46. Sprandel, U., (1985) Erythrocytes as carrier for therapeutic enzymes-an approach towards enzyme therapy of inborn errors of metabolism. Bibl. Haematol. 51, 7-14.
47. Schuchman, E., and, Muro, S., (2011) Gaucher Disease: Lessons Learned About Therapy of Lysosomal Diseases. CRC Press, Boca Raton.
48. Magnani, M., Laguerre, M., Rossi, L., Bianchi, M., Ninfali, P., et al. (1989) Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde. Alcohol Clin. Exp. Res. 13, 849-859.
49. Magnani, M., Fazi, A., Mangani, F., Rossi, L., and, Mancini, U., (1993) Methanol detoxification by enzyme-loaded erythrocytes. Biotechnol. Appl. Biochem. 18 (Pt 3), 217-226. (Pubitemid 2022755)
50. Rossi L., Bianchi, M., and, Magnani, M., (1991) Increased glucose consumption by human and mice erythrocytes overloaded with hexokinase and glucose oxidase. In Resealed Erythrocytes as Carriers and Bioreactors. (, Green, R., and, DeLoach, J. R., eds.). pp. 169-179, Pergamon Press, Oxford.
51. Ihler, G. M., Glew, R. H., and, Schnure, F. W., (1973) Enzyme loading of erythrocytes. Proc. Natl. Acad. Sci. USA 70, 2663-2666.
52. Thorpe, S. R., Fiddler, M. B., and, Desnick, R. J., (1975) Enzyme therapy. V. In vivo fate of erythrocyte-entrapped beta-glucuronidase in beta-glucuronidase-deficient mice. Pediatr. Res. 9, 918-923.
53. Bax, B. E., Bain, M. D., Ward, C. P., Fensom, A. H., and, Chalmers, R. A., (1996) The entrapment of mannose-terminated glucocerebrosidase (Alglucerase) in human carrier erythrocytes. Biochem. Soc. Trans. 24, 441S. (Pubitemid 26306436)
54. Bax, B. E., Bain, M. D., Fairbanks, L. D., Webster, A. D., Ind, P. W., et al. (2007) A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency. Eur. J. Haematol. 79, 338-348. (Pubitemid 47390137)
55. Moran, N. F., Bain, M. D., Muqit, M. M., and, Bax, B. E., (2008) Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology 71, 686-688.
56. Flynn, G., Hackett, T. J., McHale, L., and, McHale, A. P., (1994) Encapsulation of the thrombolytic enzyme, brinase, in photosensitized erythrocytes: a novel thrombolytic system based on photodynamic activation. J. Photochem. Photobiol. B 26, 193-196. (Pubitemid 24345429)
57. Ito, Y., Ogiso, T., Iwaki, M., and, Atago, H., (1987) Encapsulation of human urokinase in rabbit erythrocytes and its disposition in the circulation system in rabbits. J. Pharmacobiodyn. 10, 550-556. (Pubitemid 18082852)
58. Delahousse, B., Kravtzoff, R., and, Ropars, C., (1997) Use of erythrocytes as a new route of administration of fibrinolytic agents. Preliminary results. In Erythrocytes as Drug Carriers in Medicine. (, Sprandel, U., and, Way, J. L., eds.) pp. 35-42, Plenum Press, New York.
59. Murciano, J. C., and, Muzykantov, V. R., (2003) Coupling of anti-thrombotic agents to red blood cells offers safer and more effective management of thrombosis. Discov. Med. 3, 28-29.
60. Murciano, J. C., Medinilla, S., Eslin, D., Atochina, E., Cines, D. B., et al. (2003) Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. Nat. Biotechnol. 21, 891-896. (Pubitemid 36936194)
61. Danielyan, K., Ganguly, K., Ding, B. S., Atochin, D., Zaitsev, S., et al. (2008) Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation 118, 1442-1449.
62. Murciano, J. C., Higazi, A. A., Cines, D. B., and, Muzykantov, V. R., (2009) Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile. J. Control Release 139, 190-196.
63. Kravtzoff, R., Ropars, C., Laguerre, M., Muh, J. P., and, Chassaigne, M., (1990) Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies. J. Pharm. Pharmacol. 42, 473-476. (Pubitemid 20301482)
64. DeLoach, J. R., Andrews, K., Satterfield, W., and, Keeling, M., (1990) Intraperitoneal administration of carrier erythrocytes in dogs: an improved method for delivery of L-asparaginase. Biotechnol. Appl. Biochem. 12, 331-335. (Pubitemid 20305166)
65. Kravtzoff, R., Colombat, P. H., Desbois, I., Linassier, C., Muh, J. P., et al. (1996) Tolerance evaluation of L-asparaginase loaded in red blood cells. Eur. J. Clin. Pharmacol. 51, 221-225. (Pubitemid 26422963)
66. Updike, S. J., and, Wakamiya, R. T., (1983) Infusion of red blood cell-loaded asparaginase in monkey. Immunologic, metabolic, and toxicologic consequences. J. Lab. Clin. Med. 101, 679-691. (Pubitemid 13090031)
67. Updike, S. J., (1985) Entrapment of L-asparaginase in red blood cells. A strategy to improve treatment of acute lymphoblastic leukemia. Bibl. Haematol. 51, 65-74.
68. Lizano, C., Sanz, S., Luque, J., and, Pinilla, M., (1998) In vitro study of alcohol dehydrogenase and acetaldehyde dehydrogenase encapsulated into human erythrocytes by an electroporation procedure. Biochim. Biophys. Acta 1425, 328-336. (Pubitemid 28493342)
69. Muthuvel, A., Rajamani, R., Manikandan, S., and, Sheeladevi, R., (2006) Detoxification of formate by formate dehydrogenase-loaded erythrocytes and carbicarb in folate-deficient methanol-intoxicated rats. Clin. Chim. Acta 367, 162-169.
70. Pei, L., Omburo, G., McGuinn, W. D., Petrikovics, I., Dave, K., et al. (1994) Encapsulation of phosphotriesterase within murine erythrocytes. Toxicol. Appl. Pharmacol. 124, 296-301. (Pubitemid 24095922)
71. Garin, M., Rossi, L., Luque, J., and, Magnani, M., (1995) Lactate catabolism by enzyme-loaded red blood cells. Biotechnol. Appl. Biochem. 22 (Pt 3), 295-303.
72. Leung, P., Ray, L. E., Sander, C., Way, J. L., Sylvester, D. M., et al. (1986) Encapsulation of thiosulfate: cyanide sulfurtransferase by mouse erythrocytes. Toxicol. Appl. Pharmacol. 83, 101-107. (Pubitemid 16113510)
73. Leung, P., Cannon, E. P., Petrikovics, I., Hawkins, A., and, Way, J. L., (1991) In vivo studies on rhodanese encapsulation in mouse carrier erythrocytes. Toxicol. Appl. Pharmacol. 110, 268-274.
74. Leung, P., Davis, R. W., Yao, C. C., Cannon, E. P., and, Way, J. L., (1991) Rhodanese and sodium thiosulfate encapsulated in mouse carrier erythrocytes. II. In vivo survivability and alterations in physiologic and morphologic characteristics. Fundam. Appl. Toxicol. 16, 559-566.
75. Bustos, N. L., and, Batlle, A. M., (1989) Enzyme replacement therapy in porphyrias: V. In vivo correction of delta-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts. Drug Des. Deliv. 5, 125-131. (Pubitemid 20016100)
76. Batlle, A. M., Bustos, N. L., Stella, A. M., Wider, E. A., Conti, H. A., et al. (1983) Enzyme replacement therapy in porphyrias: IV. First successful human clinical trial of delta-aminolevulinate dehydratase-loaded erythrocyte ghosts. Int. J. Biochem. 15, 1261-1265. (Pubitemid 13024837)
77. Sanz, S., Pinilla, M., Garin, M., Tipton, K. F., and, Luque, J., (1995) The influence of enzyme concentration on the encapsulation of glutamate dehydrogenase and alcohol dehydrogenase in red blood cells. Biotechnol. Appl. Biochem. 22 (Pt 2), 223-231.
78. Sanz, S., Lizano, C., Luque, J., Pinilla, M., (1999) In vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by a hypotonic dialysis procedure. Life Sci. 65, 2781-2789.
79. Ihler, G., Lantzy, A., Purpura, J., and, Glew, R. H., (1975) Enzymatic degradation of uric acid by uricase-loaded human erythrocytes. J. Clin. Invest. 56, 595-602.
80. Magnani, M., Mancini, U., Bianchi, M., and, Fazi, A., (1992) Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. Adv. Exp. Med. Biol. 326, 189-194.
81. Hamarat, B. S., and, Uslan, A. H., (2002) In vitro study of urease/AlaDH enzyme system encapsulated into human erythrocytes and research into its medical applications. Artif. Cells Blood Substit. Immobil. Biotechnol. 30, 71-77. (Pubitemid 34438307)
82. Beutler, E., Dale, G. L., Guinto, D. E., and, Kuhl, W., (1977) Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation. Proc. Natl. Acad. Sci. USA 74, 4620-4623. (Pubitemid 8225177)
83. Bax, B. E., Bain, M. D., Fairbanks, L. D., Simmonds, H. A., Webster, A. D., et al. (2000) Carrier erythrocyte entrapped adenosine deaminase therapy in adenosine deaminase deficiency. Adv. Exp. Med. Biol. 486, 47-50. (Pubitemid 32179267)
84. Bax, B. E., Bain, M. D., Fairbanks, L. D., Webster, A. D., and, Chalmers, R. A., (2000) In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase. Br. J. Haematol. 109, 549-554. (Pubitemid 30415181)
85. Adriaenssens, K., Karcher, D., Marescau, B., Van, B. C., Lowenthal, A., et al. (1984) Hyperargininemia: the rat as a model for the human disease and the comparative response to enzyme replacement therapy with free arginase and arginase-loaded erythrocytes in vivo. Int. J. Biochem. 16, 779-786. (Pubitemid 14099877)
86. Alpar, H. O., and, Lewis, D. A., (1985) Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes. Biochem. Pharmacol. 34, 257-261. (Pubitemid 15153420)
87. Sinauridze, E. I., Vitvitsky, V. M., Pichugin, A. V., Zhabotinsky, A. M., and, Ataullakhanov, F. I., (1992) A new chemotherapeutic agent: L-asparaginase entrapped in red blood cells. Adv. Exp. Med. Biol. 326, 203-206. (Pubitemid 23047342)
88. Kwon, Y. M., Chung, H. S., Moon, C., Yockman, J., Park, Y. J., et al. (2009) L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). J. Control. Release 139, 182-189.